Transcend Therapeutics
PrivateLast Round
Series A
Feb 23, 2023
Total Funding Raised
$41.5M
Momentum Score
25 /100
Company Overview
Transcend Therapeutics is a neuroscience company that develops psychoactive medicines aimed at treating neuropsychiatric diseases by targeting specific brain areas to enhance brain function and behavior.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Mental Health, Drug Discovery
Business Model
B2B2C
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Transcend Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Transcend Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 23, 2023 | ||||
| Seed | Dec 17, 2021 |
Transcend Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Emerald Development Managers | Series A |
| Global Founders Capital | Series A |
| AlleyCorp | Series A, Seed |
| Integrated | Seed |
| FJ Labs | Series A |
| Brown Angel Group | Series A |
| Alumni Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 30, 2026
TSND-201, a neuroplastogen for PTSD, is in development.
- Jan 1, 2026
TSND-201 completes Phase 2 trials, advancing to Phase 3 in 2026.
Transcend Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Transcend Therapeutics's valuation, stock price, and market status.
